Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications
Figure 2
Reed-Sternberg cell (a) seen in a cellular background rich in lymphocytes of a classical Hodgkin’s lymphoma. Immunohistochemical expression of the activation markers CD30 (b) and CD15 (c).
